Qiagen NV Target Price

See Qiagen NV's analyst price targets ($43) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$45.79

Average Target Price

$43.01

6.1% downside

7 analysts in the last 4 months

High: $48 | Low: $38.6

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-09	UBSDoug Schenkel	$47	2.6% upside
2026-08-07	Stifel NicolausDaniel Arias	$40	12.6% downside
2026-08-07	Barclays	$40	12.6% downside
2026-08-06	Jefferies	$48	4.8% upside
2026-07-14	Berenberg BankHarry Gillis	$45.5	0.6% downside
2026-06-25	Kepler Capital	$38.6	15.7% downside
2026-06-23	Morgan Stanley	$42	8.3% downside
2026-05-18	Stifel Nicolaus	$36	21.4% downside
2026-04-30	Deutsche BankJan Koch	$43	6.1% downside
2026-04-29	BarclaysLuke Sergott	$38	17% downside
2026-04-29	Robert W. Baird	$43	6.1% downside
2026-04-14	Barclays	$44	3.9% downside
2026-02-09	UBS	$52	13.6% upside
2026-02-06	Robert W. BairdCathy Ramsey Schulte	$53	15.7% upside
2026-02-06	Stifel Nicolaus	$50	9.2% upside
2026-02-06	Barclays	$58	26.7% upside
2026-02-05	Jefferies	$59	28.8% upside
2026-01-22	Deutsche BankJan Koch	$54	17.9% upside
2025-12-15	Barclays	$57.89	26.4% upside
2025-10-02	BarclaysCatherine Ramsey Schulte	$55.79	21.8% upside
2024-10-17	HSBCShubhangi Gupt	$51.58	12.6% upside
2024-06-27	Wolfe ResearchDoug Schenkel	$52.63	14.9% upside
2024-06-18	UBSJohn Sourbeer	$48.42	5.7% upside
2021-11-04	Cowen & Co.Daniel Brennan	$61.05	33.3% upside
2021-07-15	Bank of America SecuritiesDerik De Bruin	$54.74	19.5% upside
2021-07-14	CitigroupPatrick B Donnelly	$61.05	33.3% upside
2021-07-13	Warburg ResearchUlrich Huwald	$52.89	15.5% upside

Qiagen NV (QGEN) FAQ

Qiagen NV's target price stands at $43. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $43 for QGEN implies 6.1% downside versus today's price ($45.79). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Qiagen NV's target price evolved across reporting periods, while the comparison chart places QGEN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Qiagen NV's reading of $43 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.